指引：公司预计2025年的每股收益指导范围如下：
实际值：
2024年：每股收益 $(1.81)，NAREIT 每股FFO $0.52，标准化每股FFO $1.56
2025年指导范围：
每股收益：低端 $(0.28)，高端 $(0.20)
NAREIT 每股FFO：低端 $1.44，高端 $1.48
标准化每股FFO：$1.56-$1.60
此外，公司预计2025年的同店现金 NOI 增长指导范围为 3.00% 到 3.75%，不包括 Prospect Medical 和 Steward Health 的影响。
以上内容来自Benzinga Earnings专栏，原文如下：
Guidance
The Company's 2025 per share estimated guidance ranges are as follows:
ACTUAL
2025 GUIDANCE
2024
LOW
HIGH
Earnings per share
$
(1.81
)
$
(0.28
)
$
(0.20
)
NAREIT FFO per share
$
0.52
$
1.44
$
1.48
Normalized FFO per share
$
1.56
$
1.56
$
1.60
The Company's 2025 same store cash NOI growth estimated guidance range is 3.00% to 3.75%, which excludes the impact of Prospect Medical and Steward Health.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.